Navigation Links


Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines

12/19/2014
Tigard, OR and Hershey, PA (PRWEB) December 19, 2014 Bioject Medical Technologies Inc. (OTC Pink: BJCT), a leading developer and manufacturer of needle-free injection technology, today announced that it has entered into an agreement with Immunomic Therapeutics, Inc. (“ITI”) for ITI to use the Bioject’s Biojector®-2000 needle-free injection device with its LAMP™ vaccine platform. I... [Comments]

Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1

12/19/2014
Lawrence, MA (PRWEB) December 19, 2014 Charm Sciences is pleased to announce that its lateral flow MRLAFMQ test for the Detection of Aflatoxin M1 in raw commingled milk is the first lateral flow test to receive independent third party validation. The peer reviewed report of the validation by Technology and Food Science Unit of the Institute for Agricultural and Fisheries Research (ILVO-T&am... [Comments]

BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services

12/19/2014
(PRWEB) December 19, 2014 BioPlus Specialty Pharmacy (BioPlus), one of the nation’s leading specialty pharmacies, announces the promotion of Nick Maroulis, Pharm.D. to the newly created position of Vice President of Specialty Pharmacy Services. In this position, Dr. Maroulis will continue to manage the entire specialty pharmacy while also managing the directors of our multi-site pharm... [Comments]

Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference

12/19/2014
EVANSTON, Ill. , Dec. 19, 2014 Naurex Inc., a biopharmaceutical company leveraging its unique platform to develop novel drugs for diseases of the central nervous system, today announced that Norbert Riedel , Ph.D., president and chief executive officer, will present at the 33 rd annual J.P. Morgan Healthcare Conference. Dr. Riedel's presentation will take place at 3:00 p.m.... [Comments]

Roche acquires Bina Technologies and enters the genomic informatics market

12/19/2014
PLEASANTON, Calif. , Dec. 19, 2014  Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the acquisition of Bina Technologies, Inc. (Bina), a privately held company based in Redwood City, California , USA. Bina provides a big data platform for centralized management and processing of next generation sequencing (NGS) data. Bina's proprietary on-market Genomic Manageme... [Comments]

Bina Technologies is acquired by Roche.

12/19/2014
REDWOOD CITY, Calif. , Dec. 19, 2014 Bina Technologies, Inc. (Bina, Redwood City, CA , USA) announced today that they have been acquired by Roche (SIX: RO, ROG; OTCQX: RHHBY).  Bina Technologies 1,2 is a privately held company that provides a big data platform for centralized management and processing of next generation sequencing (NGS) data for the academic and... [Comments]

Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023

12/19/2014
BURLINGTON, Mass. , Dec. 19, 2014 Decision Resources Group finds that the Latin American dental biomaterial market will grow at a 12 percent compound annual growth rate through 2023. This is primarily as a result of the aging population and the increasing adoption of dental implants. Growing aesthetic consciousness in Latin America will also spur demand for dental biomater... [Comments]

Technology Innovations in Smart Fabrics (Technical Insights)

12/19/2014
DUBLIN , Dec. 19, 2014 Research and Markets ( http://www.researchandmarkets.com/research/fhh9rj/technology ) has announced the addition of the "Technology Innovations in Smart Fabrics (Technical Insights)" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 The Research Service titled "Technology Innovations in Smart Fabrics" offers a detaile... [Comments]

BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team

12/19/2014
Altamonte Springs, FL (PRWEB) December 18, 2014 BioPlus Specialty Pharmacy (BioPlus), one of the nation’s leading specialty pharmacies, has an expanded team of Regional Pharmaceutical Care Liaisons who serve as clinical pharmacy consultants for prescriber offices in their regions, with specific areas of disease therapy expertise. “We have a variety of Regional Pharmaceutical Care Liai... [Comments]

Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors

12/19/2014
Fayetteville, Arkansas (PRWEB) December 18, 2014 Today, TiFiber, Inc. announced its plans to locate its pilot production facility and future company headquarters in Fort Smith, Arkansas to further develop and produce innovative new materials that safely and effectively control dangerous microorganisms. Fort Smith was chosen not only because of its historic, strong support for manufacturin... [Comments]

[next]
(Date:12/19/2014)... , Dec. 18, 2014 Research and Markets ... of the "Micro Market Monitor: North America Perimeter ... http://photos.prnewswire.com/prnh/20130307/600769 The ... at a CAGR of 3.6% from 2014 to 2019. ... this market, Canada is expected ...
(Date:12/17/2014)... , Dec. 15, 2014  HITLAB SM ... Clinical Practices (GCP) audit to confirm its adherence ... regulations. This accomplishment enables HITLAB to conduct regulated ... the highest principles for patient safety and research ... global healthcare access, quality, and delivery with innovative ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has ... in the APAC Region 2015-2019"  report to their ... in this market is advances in technology. With ... upgrade biometric solutions to the latest standard that ...
Breaking Biology News(10 mins):Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... of RNA inhibits prostate cancer metastasis by suppressing a surface ... team led by scientists at The University of Texas MD ... at Nature Medicine . "Our findings are the ... stem cells and also establish a strong rationale for developing ...
... Houston University of Houston professor Richard C. ... American Association for the Advancement of Science (AAAS), which ... of the journal Science . Willson is ... and biophysical sciences. He was recognized by the AAAS ...
... the fossil record to understand the evolutionary and ... their environment--are putting the dead to work. ... emerging field provides examples of how the fossil ... species will be most vulnerable to environmental changes, ...
Cached Biology News:MicroRNA suppresses prostate cancer stem cells and metastasis 2University of Houston professor named 2010 AAAS Fellow 2Putting the dead to work 2Putting the dead to work 3
... The VersArray ChipWriter Pro system with ... printing technology to array DNA, proteins, oligonucleotides, ... variety of substrates for microarray applications. This ... colonies as small as 300 micrometers in ...
Thermal printer paper is used with the thermal printer for the VersaFluor fluorometry systems. Supplied as 10 rolls....
The Freeze 'N Squeeze DNA gel extraction kit uses a quick freeze-and-thaw cycle and centrifugation to draw 50-23,000 bp DNA out of agarose gel slices. The kit includes materials for 100 preps....
... have been developed for affinity capture ... variety of ProteinChip chemical surfaces allow ... their unique biochemical properties. Each chip ... sample comparison, and the chips are ...
Biology Products:
(Date:12/19/2014)... 18, 2014 BioPlus Specialty ... specialty pharmacies, has an expanded team of Regional ... consultants for prescriber offices in their regions, with ... “We have a variety of Regional Pharmaceutical Care ... specializing in hepatitis C help prescribers understand all ...
(Date:12/19/2014)... 2014 LayerBio is an MIT spin-off ... care. The National Eye Institute (NEI) at the National ... I SBIR grant to develop a drug-eluting intraocular lens ... common cause of vision loss in people over age ... to Dr. Ken Mandell, LayerBio’s Founder and CEO, "There ...
(Date:12/19/2014)... MA (PRWEB) December 18, 2014 Reports ... in the United States suffer from one or more ... asthma, or cancer. Medication can address some of these ... daily activities that many sufferers face. While implanted nerve ... and stimulate the whole nerve, which can induce side ...
(Date:12/19/2014)... In contrast to traditional LED lights ... colors, Valoya uses proprietary LED technology to incorporate their ... uniformity which is critical in low proximity installations. The ... throughout its lifetime which is up to four times ... "The investment cost was clearly higher when compared to ...
Breaking Biology Technology:BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 2BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 3LayerBio Awarded NIH Grant to Develop a Drug Delivery Device for Cataract Surgery 2Draper Wins GSK Funding for Smaller, Smarter Implantable Devices 2
... Dec. 1, 2011  InnoPharma, Inc., a developer of sterile ... completed a $15 million Series A round of private ... Partners. "We are very pleased that InnoPharma,s ... has allowed us to attract an outstanding investor, whose ...
... Ltd. - (OTCBB: HADSY), a publicly traded portfolio of ... owned by the Hadassah University Hospital, Israel,s foremost medical ... companies have received grant approvals from the Israeli Office ... Industry, Trade and Labor. These approvals ...
... Dec. 1, 2011 Quanterix Corporation, a company enabling ... its revolutionary Si ngle Mo lecule ... been awarded a one year $250,155 contract from the ... capable of detecting single molecules of botulinum toxin (BoNT) ...
Cached Biology Technology:InnoPharma Completes $15 Million Series A Financing 2Hadasit Bio-Holdings Ltd. Reports Significant External Financing for Portfolio Companies 2Quanterix Receives Funding From the Department of Homeland Security to Develop Test for Botulinum Toxin 2Quanterix Receives Funding From the Department of Homeland Security to Develop Test for Botulinum Toxin 3